| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/BMM.13.111 |
| P698 | PubMed publication ID | 24521022 |
| P2093 | author name string | Hans Rickli | |
| Peter Ammann | |||
| Micha T Maeder | |||
| Wolfgang Korte | |||
| Roman Brenner | |||
| Lukas Trachsel | |||
| P2860 | cites work | ??? | Q28267062 |
| Epidemiology of Heart Failure and Left Ventricular Systolic Dysfunction after Acute Myocardial Infarction: Prevalence, Clinical Characteristics, and Prognostic Importance | Q22252543 | ||
| Complement. First of two parts | Q28210663 | ||
| Complement. Second of two parts | Q28211878 | ||
| Acute-phase proteins and other systemic responses to inflammation | Q28296941 | ||
| Microvasculature in acute myocardial ischemia: part I: evolving concepts in pathophysiology, diagnosis, and treatment | Q30312224 | ||
| C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction | Q33883883 | ||
| No-reflow phenomenon | Q34517875 | ||
| Myocardial reperfusion injury. | Q34687124 | ||
| ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology | Q34830023 | ||
| Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry | Q36398736 | ||
| Reduction by Cobra Venom Factor of Myocardial Necrosis after Coronary Artery Occlusion | Q37051852 | ||
| Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction | Q41118717 | ||
| Frequency, patient characteristics, and outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: lessons from 4 international fibrinolytic therapy trials | Q42692179 | ||
| The complement system in the acute phase of myocardial infarction | Q43467912 | ||
| Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial | Q43777913 | ||
| The complement system in ischemic heart disease | Q44777608 | ||
| Estimation of infarct size using transthoracic Doppler echocardiographic measurement of coronary flow reserve in infarct related and reference coronary artery | Q46235145 | ||
| C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction | Q47191457 | ||
| Strain echocardiography and wall motion score index predicts final infarct size in patients with non-ST-segment-elevation myocardial infarction | Q47450059 | ||
| Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy | Q47957724 | ||
| Admission C-reactive protein and short- as well as long-term mortality in diabetic versus non-diabetic patients with incident myocardial infarction | Q57414540 | ||
| P433 | issue | 2 | |
| P921 | main subject | acute myocardial infarction | Q18558122 |
| ventricular dysfunction | Q54911334 | ||
| P304 | page(s) | 247-258 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Biomarkers in Medicine | Q20313333 |
| P1476 | title | Complement factor concentrations in patients with acute myocardial infarction: time course and ability to predict left ventricular dysfunction. | |
| P478 | volume | 8 |
Search more.